Tumor Treating Fields therapy could potentiate immunotherapy in non-small-cell lung cancer comment

Exposure

• • intermediate frequency
  • also other exposures without EMF
• • electric current application
  • therapeutic/medical device
  • electrotherapy
• • co-exposure

Commented articles

• Leal T et al. (2023): Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study